|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Restricted cash (note 7) | ||||||||||||||||||||
| Asset held for sale (note 6) | ||||||||||||||||||||
| Accounts receivable and prepaid expenses (note 3) | ||||||||||||||||||||
| Prepaid mine deposit and acquisition costs (note 6) | ||||||||||||||||||||
| Prepaid financing costs | ||||||||||||||||||||
| Inventory (note 4) | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Non-current assets | ||||||||||||||||||||
| Spare parts inventory | ||||||||||||||||||||
| Long term deposit (note 5) | ||||||||||||||||||||
| Right-of-use asset (note 4) | ||||||||||||||||||||
| Mill Facilities (note 5) | ||||||||||||||||||||
| Right-of-use asset (note 5) | ||||||||||||||||||||
| Land (note 5) | ||||||||||||||||||||
| Bunker Hill Mine and mining interests (note 6) | ||||||||||||||||||||
| Process plant (note 6) | ||||||||||||||||||||
| Plant and equipment (note 5) | ||||||||||||||||||||
| Mineral properties and rights (note 5) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| EQUITY AND LIABILITIES | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| DSU liability (note 11) | ||||||||||||||||||||
| Interest payable (notes 6 and 7) | ||||||||||||||||||||
| Current portion of lease liability (note 7) | ||||||||||||||||||||
| Deferred share units liability (note 13) | ||||||||||||||||||||
| Deferred share units liability (note 11) | ||||||||||||||||||||
| Current portion of lease liability (note 6) | ||||||||||||||||||||
| Deferred share units liability (note 10) | ||||||||||||||||||||
| Environment protection agency cost recovery payable (note 7) | ||||||||||||||||||||
| Current portion of silver loan (note 9) | ||||||||||||||||||||
| Principal outstanding | ||||||||||||||||||||
| Stream debenture (note 10) | ||||||||||||||||||||
| Interest payable (note 8) | ||||||||||||||||||||
| Teck promissory note (note 9) | ||||||||||||||||||||
| Current income tax payable (note 13) | ||||||||||||||||||||
| Current income tax payable (note 12) | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Lease liability (note 7) | ||||||||||||||||||||
| Lease liability (note 6) | ||||||||||||||||||||
| Series 1 convertible debenture (note 8) | ||||||||||||||||||||
| Series 2 convertible debenture (note 8) | ||||||||||||||||||||
| Series 3 convertible debenture (note 8) | ||||||||||||||||||||
| Stream debenture (note 10) | ||||||||||||||||||||
| Loans Payable, Noncurrent | ||||||||||||||||||||
| Sprott Debt Facility (note 8) | ||||||||||||||||||||
| Environment protection agency cost recovery liability, net of discount (note 7) | ||||||||||||||||||||
| Deferred tax liability (note 16) | ||||||||||||||||||||
| Derivative warrant liability (note 9) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity (deficiency) | ||||||||||||||||||||
| Common stock, $0.000001 par value, 100,000,000 common stock authorized; 46,685,293 and 39,834,023 shares of common stock issued and outstanding, respectively (note 9) | ||||||||||||||||||||
| Additional paid-in-capital (note 9) | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total shareholders’ equity (deficiency) | ||||||||||||||||||||
| Total shareholders’ equity (deficiency) and liabilities | ||||||||||||||||||||
Loading...